Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MELATONINA PERRIGO 5 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/MELATONINA PERRIGO 5 MG COMPRIMIDOS

Approved

STANDARD

MELATONINA PERRIGO 5 MG COMPRIMIDOS

Perrigo Espana S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 31, 2023
Approval ID: 5da15e7285e8fb58
Company: Perrigo Espana S.A.
Type: Standard

Approval Details

Approval Id: 5da15e7285e8fb58
Drug Cima Aemps Name: MELATONINA PERRIGO 5 MG COMPRIMIDOS
Register Number: 89119
Holder Company Name: Perrigo Espana S.A.
Marketing Company Name: Perrigo Espana S.A.
Authorization Date: 2023-10-31
Dosage Form: COMPRIMIDO
Dose: 5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: No
Company Name: Perrigo Espana S.A.

Active Ingredients

MELATONINA

5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 31, 2023

Approval ID

5da15e7285e8fb58

Type

Standard

Back to CIMA-AEMPS Approvals